• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Predicting patient-reported symptom clusters in prostate cancer patients: A machine learning approach

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Rammant, E.
    Deman, E.
    Poppe, L.
    Bultijnck, R.
    Dirix, P.
    De Meerleer, G.
    Haustermans, K.
    Van Hecke, A.
    Azria, D.
    Chang-Claude, J.
    Choudhury, Ananya
    De Ruysscher, D.
    Lambrecht, M.
    Rosenstein, B. S.
    Seibold, P.
    Sperk, E.
    Symonds, R. P.
    Valdagni, R.
    Vega, A.
    Webb, A.
    West, Catharine M L
    Veldeman, L.
    Fonteyne, V.
    Van Hoecke, S.
    Show allShow less
    Affiliation
    Ghent University, Dept. of Human Structure and Repair, Ghent, Belgium
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Introduction & Objectives: Prostate cancer (PC) is the most common urological cancer in the world, with patients suffering from multiple co occurring symptoms (=symptom clusters (SC)). Identifying SC is important to anticipate on other symptoms within a SC and to uncover possibly overlooked symptoms. Also, supportive care interventions should aim to target multiple symptoms within a SC by addressing 1 or 2 symptoms and therefore alleviating the severity of other symptoms within that SC. This way, greater gains in a patients’ health-related quality of life (HRQoL) and more efficient patient care can be achieved. The aim of this study is to identify (1) SC and their changes over time in PC patients receiving radiotherapy (RT), (2) the impact of SC on HRQoL, and (3) demographic, clinical and, treatment-related predictors of SC. Materials & Methods: Data were used from REQUITE: an international prospective cohort study including PC patients receiving RT (26 hospitals, 8 countries). SC were identified based on patient-reported outcomes collected before RT(T1), end of RT(T2), month 12(T3), and month 24 after RT(T4) with the EORTC QLQ-C30 and pelvic symptom questionnaire. A combination of machine learning techniques were used to identify SC at different timepoints, to assess the impact of SC on HRQoL and to predict the SC, resp.: Hierarchical agglomerative clustering, multivariate linear regression and random forest regression. A first part of the dataset was used to develop the prediction model and a second part to validate the model for unseen data. Results: Data from 1538, 1490, 1322, and 1219 PC patients were analysed at T1, T2, T3 and T4, respectively. Three SC were identified at T1: SC1 (gastro-intestinal symptoms), SC2 (fatigue, urinary symptoms, emotional and cognitive functioning), and SC3 (pain, physical, role, and social functioning). At T2, changes in SC were seen: SC1 (gastro-intestinal symptoms), SC2 (fatigue, urinary problems, insomnia), SC3 (social and role functioning), and SC4 (pain, bowel problems, physical, emotional and cognitive functioning). At T3, SC returned to the 3 T1 SC and remained more or less stable at T4 (‘fatigue’ left SC2 and clustered together with ‘dyspnoea’ (SC4)). SC including ‘fatigue’ or ‘urinary symptoms’ had the highest frequencies across time-points. At T1, T3 and T4, cluster 2 and 3 (35-45% explained variance) had the strongest impact on the patients’ overall HRQoL. At T2, cluster 4 (52%) had the strongest impact. Planned RT target volume, PSA at prediagnostic biopsy, age and alcohol consumption were the best predictors of SC2 at T2 and SC3 and SC4 at T4. Conclusions: Several SC were identified in PC patients receiving RT. Although SC including fatigue and urinary symptoms were most common across time-points, the ‘pain, bowel problems, physical, emotional and cognitive functioning’ SC at T2 had the strongest impact on HRQoL. The predictors can be used to tailor future interventions.
    Citation
    Rammant E, Deman E, Poppe L, Bultijnck R, Dirix P, De Meerleer G, et al. Predicting patient-reported symptom clusters in prostate cancer patients: A machine learning approach. European Urology. 2022 Feb;81:S1687-S8. PubMed PMID: WOS:000812320401536.
    Journal
    European Urology
    URI
    http://hdl.handle.net/10541/625514
    Type
    Meetings and Proceedings
    Collections
    All Paterson Institute for Cancer Research

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.